BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK. The aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future.
BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit their website.
The Results Healthcare team will be at BioTrinity 2019 on the 1 May, and we are looking forward to meeting new and old contacts as well as being a part of the conversations that will frame our industry. If you are planning on attending then contact us to organise a meeting where we can discuss industry trends, recent M&A transactions and valuations, as well as your company strategy.